stellamune mycoplasma vet injektioneste, emulsio
elanco gmbh - mycoplasma hyopneumoniae j kanta inaktivoitu - injektioneste, emulsio - mykoplasma rokote
mycophenolate mofetil accord 500 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - mofetil mycophenolate - tabletti, kalvopäällysteinen - 500 mg - mykofenolihappo
mycophenolate mofetil accord 250 mg kapseli, kova
accord healthcare b.v. - mofetil mycophenolate - kapseli, kova - 250 mg - mykofenolihappo
mycophenolate mofetil orion 250 mg kapseli, kova
orion corporation orion pharma orion corporation orion pharma - mofetilis mycophenolas - kapseli, kova - 250 mg - mykofenolihappo
mycophenolate mofetil sandoz 500 mg tabletti, kalvopäällysteinen
sandoz a/s - mofetil mycophenolate - tabletti, kalvopäällysteinen - 500 mg - mykofenolihappo
mycophenolate mofetil hexal 500 mg tabletti, kalvopäällysteinen
hexal a/s - mofetil mycophenolate - tabletti, kalvopäällysteinen - 500 mg - mykofenolihappo
mycophenolate mofetil hexal 250 mg kapseli, kova
hexal a/s - mofetil mycophenolate - kapseli, kova - 250 mg - mykofenolihappo
mycophenolate mofetil teva
teva pharma b.v. - mykofenolaattimofetiili - graft hylkääminen - immunosuppressantit - mykofenolaattimofetiili teva on tarkoitettu käytettäväksi yhdessä ciclosporin ja kortikosteroideja akuutti hylkimisreaktion potilaille, jotka saavat allogeenisten munuaisten, sydämen tai maksan elinsiirrot ennaltaehkäisyyn.
circomax myco
zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologiset suidaeille - siat (lihotus) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection. onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination. duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination. in addition, vaccination has been shown to reduce body weight gain losses under field conditions.
mycophenolate mofetil orion 500 mg tabletti, kalvopäällysteinen
orion corporation - mofetilis mycophenolas - tabletti, kalvopäällysteinen - 500 mg - mykofenolihappo